Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15495095rdf:typepubmed:Citationlld:pubmed
pubmed-article:15495095lifeskim:mentionsumls-concept:C0017119lld:lifeskim
pubmed-article:15495095lifeskim:mentionsumls-concept:C1524062lld:lifeskim
pubmed-article:15495095lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:15495095lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:15495095lifeskim:mentionsumls-concept:C0521112lld:lifeskim
pubmed-article:15495095lifeskim:mentionsumls-concept:C0240526lld:lifeskim
pubmed-article:15495095pubmed:issue4lld:pubmed
pubmed-article:15495095pubmed:dateCreated2004-10-20lld:pubmed
pubmed-article:15495095pubmed:abstractTextNocturnal gastric acid breakthrough(NAB) is defined as intragastric pH<4 for more than one continuous hour overnight. Adding H2-receptor antagonists (H2RAs)at bedtime to high-dose proton pump inhibitors is likely to enhance nocturnal gastric pH control and decrease nocturnal gastric acid breakthrough.lld:pubmed
pubmed-article:15495095pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15495095pubmed:languageenglld:pubmed
pubmed-article:15495095pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15495095pubmed:citationSubsetIMlld:pubmed
pubmed-article:15495095pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15495095pubmed:statusMEDLINElld:pubmed
pubmed-article:15495095pubmed:issn1469-493Xlld:pubmed
pubmed-article:15495095pubmed:authorpubmed-author:SenS PSPlld:pubmed
pubmed-article:15495095pubmed:authorpubmed-author:WangYipingYlld:pubmed
pubmed-article:15495095pubmed:authorpubmed-author:WangQiongQlld:pubmed
pubmed-article:15495095pubmed:authorpubmed-author:GuoZhengZlld:pubmed
pubmed-article:15495095pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15495095pubmed:ownerNLMlld:pubmed
pubmed-article:15495095pubmed:authorsCompleteYlld:pubmed
pubmed-article:15495095pubmed:paginationCD004275lld:pubmed
pubmed-article:15495095pubmed:dateRevised2009-12-8lld:pubmed
pubmed-article:15495095pubmed:meshHeadingpubmed-meshheading:15495095...lld:pubmed
pubmed-article:15495095pubmed:meshHeadingpubmed-meshheading:15495095...lld:pubmed
pubmed-article:15495095pubmed:meshHeadingpubmed-meshheading:15495095...lld:pubmed
pubmed-article:15495095pubmed:meshHeadingpubmed-meshheading:15495095...lld:pubmed
pubmed-article:15495095pubmed:meshHeadingpubmed-meshheading:15495095...lld:pubmed
pubmed-article:15495095pubmed:year2004lld:pubmed
pubmed-article:15495095pubmed:articleTitleAdditional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough.lld:pubmed
pubmed-article:15495095pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15495095pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15495095lld:pubmed